etoposide has been researched along with embelin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fang, X; Guo, R; Hu, Z; Li, P; Lippman, ME; Nikolovska-Coleska, Z; Roller, PP; Tomita, Y; Wang, R; Wang, S; Xu, L; Yang, D; Zhang, M | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for etoposide and embelin
Article | Year |
---|---|
Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.
Topics: Antineoplastic Agents; Apoptosis; Ardisia; Benzoquinones; Caspase 9; Caspases; Cell Division; Cell Line, Tumor; Computer Simulation; Databases, Factual; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Enzyme Activation; Fluorescence Polarization; Humans; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Molecular Weight; Plant Preparations; Proteins; X-Linked Inhibitor of Apoptosis Protein | 2004 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |